Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Front Immunol ; 14: 1141731, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37359536

RESUMEN

Delayed wound healing is a devastating complication of diabetes and supplementation with fish oil, a source of anti-inflammatory omega-3 (ω-3) fatty acids including eicosapentaenoic acid (EPA), seems an appealing treatment strategy. However, some studies have shown that ω-3 fatty acids may have a deleterious effect on skin repair and the effects of oral administration of EPA on wound healing in diabetes are unclear. We used streptozotocin-induced diabetes as a mouse model to investigate the effects of oral administration of an EPA-rich oil on wound closure and quality of new tissue formed. Gas chromatography analysis of serum and skin showed that EPA-rich oil increased the incorporation of ω-3 and decreased ω-6 fatty acids, resulting in reduction of the ω-6/ω-3 ratio. On the tenth day after wounding, EPA increased production of IL-10 by neutrophils in the wound, reduced collagen deposition, and ultimately delayed wound closure and impaired quality of the healed tissue. This effect was PPAR-γ-dependent. EPA and IL-10 reduced collagen production by fibroblasts in vitro. In vivo, topical PPAR-γ-blockade reversed the deleterious effects of EPA on wound closure and on collagen organization in diabetic mice. We also observed a reduction in IL-10 production by neutrophils in diabetic mice treated topically with the PPAR-γ blocker. These results show that oral supplementation with EPA-rich oil impairs skin wound healing in diabetes, acting on inflammatory and non-inflammatory cells.


Asunto(s)
Diabetes Mellitus Experimental , Diabetes Mellitus Tipo 1 , Ácidos Grasos Omega-3 , Animales , Ratones , Ácido Eicosapentaenoico/farmacología , Interleucina-10/farmacología , PPAR gamma , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Cicatrización de Heridas , Colágeno/metabolismo , Suplementos Dietéticos
2.
J Am Soc Nephrol ; 26(8): 1877-88, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25589612

RESUMEN

Short-chain fatty acids (SCFAs) are fermentation end products produced by the intestinal microbiota and have anti-inflammatory and histone deacetylase-inhibiting properties. Recently, a dual relationship between the intestine and kidneys has been unraveled. Therefore, we evaluated the role of SCFA in an AKI model in which the inflammatory process has a detrimental role. We observed that therapy with the three main SCFAs (acetate, propionate, and butyrate) improved renal dysfunction caused by injury. This protection was associated with low levels of local and systemic inflammation, oxidative cellular stress, cell infiltration/activation, and apoptosis. However, it was also associated with an increase in autophagy. Moreover, SCFAs inhibited histone deacetylase activity and modulated the expression levels of enzymes involved in chromatin modification. In vitro analyses showed that SCFAs modulated the inflammatory process, decreasing the maturation of dendritic cells and inhibiting the capacity of these cells to induce CD4(+) and CD8(+) T cell proliferation. Furthermore, SCFAs ameliorated the effects of hypoxia in kidney epithelial cells by improving mitochondrial biogenesis. Notably, mice treated with acetate-producing bacteria also had better outcomes after AKI. Thus, we demonstrate that SCFAs improve organ function and viability after an injury through modulation of the inflammatory process, most likely via epigenetic modification.


Asunto(s)
Lesión Renal Aguda/prevención & control , Ácidos Grasos Volátiles/uso terapéutico , Daño por Reperfusión/prevención & control , Lesión Renal Aguda/metabolismo , Animales , Bifidobacterium , Línea Celular , Células Dendríticas/metabolismo , Evaluación Preclínica de Medicamentos , Inflamación/tratamiento farmacológico , Masculino , Ratones Endogámicos C57BL , Estrés Oxidativo , Probióticos/uso terapéutico , Daño por Reperfusión/metabolismo
3.
Int J Food Sci Nutr ; 64(5): 561-9, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23317109

RESUMEN

This study investigated the effects of mate tea (Ilex paraguariensis) aqueous extract consumption on metabolic indicators and inflammatory response of peritoneal macrophages in rats fed a high-fat diet (HFD). Male Wistar rats were fed a control diet or a HFD for 12 weeks. At the end of this period, rats received, or not, daily doses of yerba maté for 4 weeks. The consumption of yerba maté promoted weight loss, attenuated the HFD-detrimental effects on adiposity and insulin sensitivity and decreased blood levels of the inflammatory biomarkers (p < 0.05). Concerning peritoneal macrophages, mate tea consumption decreased the production of interleukin (IL)-6, but did not influence the production of IL-1ß, tumour necrosis factor-α and nitric oxide; cytokine mRNA expression; or the activation of the nuclear factor-κB signalling pathway. In summary, the consumption of mate tea had no consistent effect in the inflammatory response of peritoneal macrophages, but reduced cardiometabolic risk markers.


Asunto(s)
Adiposidad/efectos de los fármacos , Ilex paraguariensis , Inflamación/tratamiento farmacológico , Resistencia a la Insulina , Obesidad/tratamiento farmacológico , Fitoterapia , Pérdida de Peso/efectos de los fármacos , Animales , Biomarcadores/sangre , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/prevención & control , Citocinas/genética , Citocinas/metabolismo , Dieta Alta en Grasa , Inflamación/etiología , Inflamación/metabolismo , Mediadores de Inflamación/sangre , Mediadores de Inflamación/metabolismo , Interleucina-6/metabolismo , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/metabolismo , FN-kappa B/metabolismo , Óxido Nítrico/metabolismo , Obesidad/sangre , Obesidad/etiología , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas , Ratas Wistar , Transducción de Señal , Factor de Necrosis Tumoral alfa/metabolismo
4.
J Biomed Biotechnol ; 2012: 945131, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22988427

RESUMEN

High consumption of polyunsaturated fatty acids, such as sunflower oil has been associated to beneficial effects in plasma lipid profile, but its role on inflammation and insulin resistance is not fully elucidated yet. We evaluated the effect of sunflower oil supplementation on inflammatory state and insulin resistance condition in HFD-induced obese mice. C57BL/6 male mice (8 weeks) were divided in four groups: (a) control diet (CD), (b) HFD, (c) CD supplemented with n-6 (CD + n-6), and (d) HFD supplemented with n-6 (HFD + n-6). CD + n-6 and HFD + n-6 were supplemented with sunflower oil by oral gavage at 2 g/Kg of body weight, three times per week. CD and HFD were supplemented with water instead at the same dose. HFD induced whole and muscle-specific insulin resistance associated with increased inflammatory markers in insulin-sensitive tissues and macrophage cells. Sunflower oil supplementation was not efficient in preventing or reducing these parameters. In addition, the supplementation increased pro-inflammatory cytokine production by macrophages and tissues. Lipid profile, on the other hand, was improved with the sunflower oil supplementation in animals fed HFD. In conclusion, sunflower oil supplementation improves lipid profile, but it does not prevent or attenuate insulin resistance and inflammation induced by HFD in C57BL/6 mice.


Asunto(s)
Grasas de la Dieta/efectos adversos , Suplementos Dietéticos , Inflamación/inducido químicamente , Resistencia a la Insulina , Obesidad/tratamiento farmacológico , Obesidad/fisiopatología , Aceites de Plantas/administración & dosificación , Aceites de Plantas/efectos adversos , Animales , Inflamación/fisiopatología , Masculino , Ratones , Ratones Endogámicos C57BL , Obesidad/etiología , Aceite de Girasol
5.
Amino Acids ; 39(2): 435-41, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20094742

RESUMEN

The aim of this study was to evaluate the effect of glutamine on the expression of proteins involved in the nuclear factor-kappaB (NF-kappaB) signaling pathway of murine peritoneal macrophages. Since glutamine is essential for the normal functioning of macrophages, it was hypothesized that in vitro glutamine supplementation would increase NF-kappaB activation. Peritoneal macrophages were pretreated with glutamine (0, 0.6, 2 and 10 mM) before incubation with lipopolysaccharide (LPS), and the effects of glutamine on the production of tumor necrosis factor-alpha and on the expression and activity of proteins involved in the NF-kappaB signaling pathway were studied by an enzyme linked immuno-sorbent assay, Western blotting, and an electrophoretic mobility shift assay. Glutamine treatment (2 and 10 mM) increased the activation of NF-kappaB in LPS-stimulated peritoneal macrophages (P < 0.05). In non-stimulated cells, glutamine treatment (2 and 10 mM) significantly reduced I kappaB-alpha protein expression (P < 0.05). Glutamine modulates NF-kappaB signaling pathway by reducing the level of I kappaB-alpha, leading to an increase in NF-kappaB within the nucleus in peritoneal macrophages.


Asunto(s)
Glutamina/farmacología , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/fisiología , FN-kappa B/fisiología , Transducción de Señal/efectos de los fármacos , Animales , Quinasa I-kappa B/metabolismo , Lipopolisacáridos/farmacología , Masculino , Ratones , Ratones Endogámicos BALB C , Factor de Necrosis Tumoral alfa/biosíntesis
6.
J Nutr ; 138(7): 1343-8, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18567758

RESUMEN

Infants who are breast-fed have been shown to have a lower incidence of certain infectious diseases compared with formula-fed infants. Glutamine is one of the most abundant amino acids found in maternal milk and it is essential for the function of immune system cells such as macrophages. The purpose of this study was to investigate the effect of glutamine supplementation on the function of peritoneal macrophages and on hemopoiesis in early-weaned mice inoculated with Mycobacterium bovis bacillus Calmette-Guérin (BCG). Mice were weaned at 14 d of age and distributed to 2 groups and fed either a glutamine-free diet (n = 16) or a glutamine-supplemented diet (+Gln) (n = 16). Both diets were isonitrogenous (with addition of a mixture of nonessential amino acids) and isocaloric. At d 21, 2 subgroups of mice (n = 16) were intraperitoneally injected with BCG and all mice were killed at d 28. Plasma, muscle and liver glutamine concentrations and muscle glutamine synthetase activity were not affected by diet or inoculation with BCG. The +Gln diet led to increased leukocyte and lymphocyte counts in the peripheral blood (P < 0.05) and granulocyte and lymphocyte counts in the bone marrow and spleen (P < 0.05). The +Gln diet increased spreading and adhesion capacities, hydrogen peroxide, nitric oxide, and tumor necrosis factor-alpha (TNFalpha) syntheses and the phagocytic and fungicidal activity of peritoneal macrophages (P < 0.05). The interaction between the +Gln diet and BCG inoculation increased the area under the curve of interleukin (IL)-1beta and TNFalpha syntheses (P < 0.05). In conclusion, the intake of glutamine increases the function of peritoneal macrophages and hemopoiesis in early-weaned and BCG-inoculated mice. These data have important implications for the design of breast milk substitutes for human infants.


Asunto(s)
Vacuna BCG/administración & dosificación , Glutamina/administración & dosificación , Hematopoyesis/efectos de los fármacos , Hematopoyesis/inmunología , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/inmunología , Animales , Animales Recién Nacidos , Suplementos Dietéticos , Glutamina/metabolismo , Humanos , Lactante , Fórmulas Infantiles , Recién Nacido , Masculino , Ratones , Leche/inmunología , Leche/metabolismo , Destete
7.
Clin Nutr ; 27(3): 386-97, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18457905

RESUMEN

BACKGROUND & AIMS: To investigate the effect that early weaning associated with the ingestion of either a glutamine-free or supplemented diet has on the functioning of peritoneal macrophages, hematopoiesis and nutritional status of mice. METHODS: Swiss Webster mice were early weaned on their 14th day of life and distributed to two groups, being fed either a glutamine-free diet (-GLN) or a glutamine-supplemented diet (+GLN). Animals belonging to a control group (CON) were weaned on their 21st day of life. RESULTS: The -GLN and +GLN groups had a lower lean body mass, carcass protein and ash content, plasma glutamine concentration and lymphocyte counts both in the peripheral blood and bone marrow when compared to the CON group (P<0.05). Dietary supplementation with glutamine reversed both the lower concentrations of protein and DNA in the muscle and liver, as well as the reduced capacity of spreading and synthesizing nitric oxide, hydrogen peroxide, TNF-alpha, IL-1 beta and IL-6 in cultures of peritoneal macrophages obtained from the -GLN group (P<0.05). CONCLUSION: These data indicate that the ingestion of glutamine modulates the function of peritoneal macrophages in early weaned mice. However, a glutamine-supplemented diet cannot substitute maternal milk in respect to immunological and metabolic parameters.


Asunto(s)
Glutamina/farmacología , Hematopoyesis/efectos de los fármacos , Macrófagos Peritoneales/efectos de los fármacos , Estado Nutricional , Destete , Animales , Animales Recién Nacidos , Suplementos Dietéticos , Glutamina/inmunología , Hematopoyesis/fisiología , Macrófagos Peritoneales/inmunología , Masculino , Ratones , Leche/inmunología , Leche/metabolismo , Distribución Aleatoria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA